Understanding drug addiction: A neuropsychological perspective

Australian and New Zealand Journal of Psychiatry

Volumn 41, Issue 12, 2007, Pages 957-968

  Yücel, Murat ^a,b   Lubman, Dan I ^a   Solowij, Nadia ^c   Brewer, Warrick J ^a  

^a ORYGEN RESEARCH CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Brain; Cognition; Drug; Imaging; Vulnerability

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE; CANNABIS; COCAINE; METHAMPHETAMINE; OPIATE; PSYCHOSTIMULANT AGENT;

ADOLESCENT DEVELOPMENT; ALCOHOLISM; BASAL GANGLION; BEHAVIOR DISORDER; BRAIN MATURATION; CANNABIS ADDICTION; COCAINE DEPENDENCE; COGNITION; COMORBIDITY; DECISION MAKING; DRUG DEPENDENCE; DRUG EXPOSURE; FRONTAL CORTEX; HUMAN; INHIBITION (PSYCHOLOGY); MEDLINE; MENTAL DISEASE; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; NEUROIMAGING; NEUROPSYCHOLOGY; PERSONALITY DISORDER; REVIEW; SUBSTANCE ABUSE; TEMPORAL CORTEX; WORKING MEMORY;

ADOLESCENT; ADULT; AGE FACTORS; ALCOHOLISM; ANALGESICS, OPIOID; BEHAVIOR, ADDICTIVE; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION DISORDERS; COMORBIDITY; HUMANS; MARIJUANA ABUSE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; OPIOID-RELATED DISORDERS; SUBSTANCE-RELATED DISORDERS;

EID: 36249011331     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1080/00048670701689444     Document Type: Review

References (142)

1. Bechara, A., Dolan, S., Denburg, N., Hindes, A., Anderson, SW and Nathan, PE. (2001) Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia, 39, pp. 376-389.
2. Fillmore, MT. (2003) Drug abuse as a problem of impaired control: current approaches and findings. Behav Cogn Neurosci Rev, 2, pp. 179-197.
3. Goldstein, RZ and Volkow, ND. (2002) Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry, 159, pp. 1642-1652.
4. Grant, S., Contoreggi, C. and London, ED. (2000) Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia, 38, pp. 1180-1187.
5. Jentsch, JD and Taylor, JR. (1999) Impulsivity resulting from frontostriatal dysfunction in drug abuse: Implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl), 146, pp. 373-390.
6. Lubman, DI, Yucel, M. and Pantelis, C. (2004) Addiction, a condition of compulsive behaviour? Neuroimaging and neuropsychological evidence of inhibitory dysregulation. Addiction, 99, pp. 1491-1502.
7. Yucel, M. and Lubman, DI. (2007) Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention. Drug Alcohol Rev, 26, pp. 33-39.
8. Volkow, ND, Hitzemann, R. and Wang, GJ (1992) Long-term frontal brain metabolic changes in cocaine abusers. Synapse, 11, pp. 184-190.
9. Yucel, M., Lubman, DI and Harrison, BJ (2007) A combined spectroscopic and functional MRI investigation of the dorsal anterior cingulate region in opiate addiction. Mol Psychiatry, 12, pp. 691-702.
10. Yucel, M., Lubman, DI and Harrison, BJ (2007) Neuronal, physiological and brain-behavioural abnormalities in opiate-addicted individuals. Mol Psychiatry, 12, p. 611.
11. Fishbein, DH, Herman-Stahl, M. and Eldreth, D. (2006) Mediators of the stress-substance-use relationship in urban male adolescents. Prev Sci, 7, pp. 113-126.
12. Bowden-Jones, H., McPhillips, M., Rogers, R., Hutton, S. and Joyce, E. (2005) Risk-taking on tests sensitive to ventromedial prefrontal cortex dysfunction predicts early relapse in alcohol dependency: A pilot study. J Neuropsychiatry Clin Neurosci, 17, pp. 417-420.
13. Scheurich, A. (2005) Neuropsychological functioning and alcohol dependence. Curr Opin Psychiatry, 18, pp. 319-323.
14. Corral-Varela, M. and Cadaveira, F. (2002) Neuropsychological aspects of alcohol dependence: The nature of brain damage and its reversibility]. Rev Neurol, 35, pp. 682-687.
15. Parsons, OA. (1998) Neurocognitive deficits in alcoholics and social drinkers: A continuum?. Alcohol Clin Exp Res, 22, pp. 954-961.
16. Beatty, WW, Tivis, R., Stott, HD, Nixon, SJ and Parsons, OA. (2000) Neuropsychological deficits in sober alcoholics: Influences of chronicity and recent alcohol consumption. Alcohol Clin Exp Res, 24, pp. 149-154.
17. Parsons, OA and Nixon, SJ. (1998) Cognitive functioning in sober social drinkers: A review of the research since 1986. J Stud Alcohol, 59, pp. 180-190.
18. Eckardt, MJ, File, SE and Gessa, G. (1998) Effects of moderate alcohol consumption on the central nervous system. Alcohol Clin Exp Res, 22, pp. 998-1040.
19. Solomon, DA and Malloy, PF. (1992) Alcohol, head injury, and neuropsychological function. Neuropsychol Rev, 3, pp. 249-280.
20. Mann, K., Agartz, I. and Harper, C. (2001) Neuroimaging in alcoholism: ethanol and brain damage. Alcohol Clin Exp Res, 25, pp. 104S-109S.
21. Pfefferbaum, A., Sullivan, EV, Mathalon, DH and Lim, KO. (1997) Frontal lobe volume loss observed with magnetic resonance imaging in older chronic alcoholics. Alcohol Clin Exp Res, 21, pp. 521-529.
22. Hommer, D., Momenan, R., Kaiser, E. and Rawlings, R. (2001) Evidence for a gender-related effect of alcoholism on brain volumes. Am J Psychiatry, 158, pp. 198-204.
23. Hommer, D., Momenan, R. and Rawlings, R. (1996) Decreased corpus callosum size among alcoholic women. Arch Neurol, 53, pp. 359-363.
24. Sullivan, EV, Rosenbloom, MJ, Lim, KO and Pfefferbaum, A. (2000) Longitudinal changes in cognition, gait, and balance in abstinent and relapsed alcoholic men: Relationships to changes in brain structure. Neuropsychology, 14, pp. 178-188.
25. Sullivan, EV, Rosenbloom, MJ and Pfefferbaum, A. (2000) Pattern of motor and cognitive deficits in detoxified alcoholic men. Alcohol Clin Exp Res, 24, pp. 611-621.
26. Volkow, ND, Wang, GJ and Hitzemann, R. (1994) Recovery of brain glucose metabolism in detoxified alcoholics. Am J Psychiatry, 151, pp. 178-183.
27. Grant, I., Gonzalez, R., Carey, CL, Natarajan, L. and Wolfson, T. (2003) Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study. J Int Neuropsychol Soc, 9, pp. 679-689.
28. Fletcher, JM, Page, JB and Francis, DJ (1996) Cognitive correlates of long-term cannabis use in Costa Rican men. Arch Gen Psychiatry, 53, pp. 1051-1057.
29. Pope Jr, HG and Yurgelun-Todd, D. (1996) The residual cognitive effects of heavy marijuana use in college students. JAMA, 275, pp. 521-527.
30. Pope Jr, HG, Gruber, AJ, Hudson, JI, Cohane, G., Huestis, MA and Yurgelun-Todd, D. (2003) Early-onset cannabis use and cognitive deficits: What is the nature of the association?. Drug Alcohol Depend, 69, pp. 303-310.
31. Pope Jr, HG, Gruber, AJ, Hudson, JI, Huestis, MA and Yurgelun-Todd, D. (2001) Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry, 58, pp. 909-915.
32. Bolla, KI, Brown, K., Eldreth, D., Tate, K. and Cadet, JL. (2002) Dose-related neurocognitive effects of marijuana use. Neurology, 59, pp. 1337-1343.
33. Solowij, N., Stephens, RS and Roffman, RA (2002) Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA, 287, pp. 1123-1131.
34. Eldreth, DA, Matochik, JA, Cadet, JL and Bolla, KI. (2004) Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage, 23, pp. 914-920.
35. Solowij, N. (1998) Cannabis and cognitive functioning, Cambridge University Press, Cambridge
36. Block, RI, O'Leary, DS and Ehrhardt, JC (2000) Effects of frequent marijuana use on brain tissue volume and composition. Neuroreport, 11, pp. 491-496.
37. Kanayama, G., Rogowska, J., Pope, HG, Gruber, SA and Yurgelun-Todd, DA. (2004) Spatial working memory in heavy cannabis users: A functional magnetic resonance imaging study. Psychopharmacology (Berl), 176, pp. 239-247.
38. Smith, A., Fried, P., Hogan, M. and Cameron, I. (2004) The effects of prenatal and current marijuana exposure on response inhibition: A functional magnetic resonance imaging study. Brain Cogn, 54, pp. 147-149.
39. Gruber, SA and Yurgelun-Todd, DA. (2005) Neuroimaging of marijuana smokers during inhibitory processing: A pilot investigation. Brain Res Cogn Brain Res, 23, pp. 107-118.
40. Bolla, KI, Eldreth, DA, Matochik, JA and Cadet, JL. (2005) Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage, 26, pp. 480-492.
41. Matochik, JA, Eldreth, DA, Cadet, JL and Bolla, KI. (2005) Altered brain tissue composition in heavy marijuana users. Drug Alcohol Depend, 77, pp. 23-30.
42. Tzilos, GK, Cintron, CB and Wood, JB (2005) Lack of hippocampal volume change in long-term heavy cannabis users. Am J Addict, 14, pp. 64-72.
43. Brust, J. (1993) Neurological aspects of substance abuse, Butterworth-Heinemann, Boston
44. Lubman, DI, Hides, L. and Yucel, M. (2006) Inhalant misuse in youth: time for a coordinated response. Med J Aust, 185, pp. 327-330.
45. Rosenberg, NL, Grigsby, J., Dreisbach, J., Busenbark, D. and Grigsby, P. (2002) Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse. J Toxicol Clin Toxicol, 40, pp. 21-34.
46. Maruff, P., Burns, CB, Tyler, P., Currie, BJ and Currie, J. (1998) Neurological and cognitive abnormalities associated with chronic petrol sniffing. Brain, 121, pp. 1903-1917.
47. Chadwick, O., Anderson, R., Bland, M. and Ramsey, J. (1989) Neuropsychological consequences of volatile substance abuse: A population based study of secondary school pupils. BMJ, 298, pp. 1679-1683.
48. Takagi, M., Lubman, DI and Yücel, M. Interpreting neuropsychological impairment amongst adolescent inhalant users: Two case reports. Acta Neuropsychiatr
49. Yamanouchi, N., Okada, S. and Kodama, K. (1995) White matter changes caused by chronic solvent abuse. AJNR Am J Neuroradiol, 16, pp. 1643-1649.
50. Yamanouchi, N., Okada, S. and Kodama, K. (1997) Effects of MRI abnormalities on WAIS-R performance in solvent abusers. Acta Neurol Scand, 96, pp. 34-39.
51. Cairney, S., Maruff, P., Burns, CB, Currie, J. and Currie, BJ. (2004) Saccade dysfunction associated with chronic petrol sniffing and lead encephalopathy. J Neurol Neurosurg Psychiatry, 75, pp. 472-476.
52. Cairney, S., Maruff, P., Burns, CB, Currie, J. and Currie, BJ. (2005) Neurological and cognitive recovery following abstinence from petrol sniffing. Neuropsychopharmacology, 30, pp. 1019-1027.
53. Caldemeyer, K., Pascuzzi, R., Moran, C. and Smith, R. (1993) Toluene abuse causing reduced MR signal intensity in the brain. AJR Am J Roentgenol, 161, pp. 1259-1261.
54. Ehyai, A. and Freemon, F. (1983) Progressive optic neuropathy and sensorineural hearing loss due to chronic glue sniffing. J Neurol Neurosurg Psychiatry, 46, pp. 349-348.
55. Ryu, Y., Lee, J., Yoon, P., Jeon, P., Kim, D. and Shin, D. (1998) Cerebral perfusion impairment in a patient with toluene abuse. J Nucl Med, 39, pp. 632-633.
56. Aydin, K., Sencer, S., Ogel, K., Genchellac, H., Demir, T. and Minareci, O. (2003) Single-voxel proton MR spectroscopy in toluene abuse. Magn Reson Imaging, 21, pp. 777-785.
57. Filley, C., Heaton, RK and Rosenberg, NL. (1990) White matter dementia in chronic toluene abuse. Neurology, 40, pp. 532-534.
58. Deleu, D. and Hanssens, Y. (2000) Toluene induced postural tremor. J Neurol Neurosurg Psychiatry, 68, p. 118.
59. Rosenberg, NI, Kleinschmidt-DeMasters, BK, Davis, KA, Dreisbach, JN, Hormes, JT and Filley, CM. (1988) Toluene abuse causes diffuse central nervous system white matter changes. Ann Neurol, 23, pp. 611-614.
60. Davis, PE, Liddiard, H. and McMillan, TM. (2002) Neuropsychological deficits and opiate abuse. Drug Alcohol Depend, 67, pp. 105-108.
61. Pau, CW, Lee, TM and Chan, SF. (2002) The impact of heroin on frontal executive functions. Arch Clin Neuropsychol, 17, pp. 663-670.
62. Guerra, D., Sole, A., Cami, J. and Tobena, A. (1987) Neuropsychological performance in opiate addicts after rapid detoxification. Drug Alcohol Depend, 20, pp. 261-270.
63. Ornstein, TJ, Iddon, JL and Baldacchino, AM (2000) Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology, 23, pp. 113-126.
64. Rogers, RD, Everitt, BJ and Baldacchino, A. (1999) Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: Evidence for monoaminergic mechanisms. Neuropsychopharmacology, 20, pp. 322-339.
65. Lee, TM and Pau, CW. (2002) Impulse control differences between abstinent heroin users and matched controls. Brain Inj, 16, pp. 885-889.
66. Darke, S., Sims, J., McDonald, S. and Wickes, W. (2000) Cognitive impairment among methadone maintenance patients. Addiction, 95, pp. 687-695.
67. Ersche, KD, Fletcher, PC and Lewis, SJ (2005) Abnormal frontal activations related to decision-making in current and former amphetamine and opiate dependent individuals. Psychopharmacology (Berl), 180, pp. 612-623.
68. Lyoo, IK, Pollack, MH and Silveri, MM (2006) Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology (Berl), 184, pp. 139-144.
69. Kivisaari, R., Kahkonen, S., Puuskari, V., Jokela, O., Rapeli, P. and Autti, T. (2004) Magnetic resonance imaging of severe, long-term, opiate-abuse patients without neurologic symptoms may show enlarged cerebrospinal spaces but no signs of brain pathology of vascular origin. Arch Med Res, 35, pp. 395-400.
70. Ersche, KD, Clark, L., London, M., Robbins, TW and Sahakian, BJ. (2006) Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology, 31, pp. 1036-1047.
71. Maxwell, JC. (2005) Emerging research on methamphetamine. Curr Opin Psychiatry, 18, pp. 235-242.
72. Nordahl, TE, Salo, R. and Leamon, M. (2003) Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: A review. J Neuropsychiatry Clin Neurosci, 15, pp. 317-325.
73. Rippeth, JD, Heaton, RK and Carey, CL (2004) Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc, 10, pp. 1-14.
74. Salo, R., Nordahl, TE and Possin, K. (2002) Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Res, 111, pp. 65-74.
75. Gonzalez, R., Rippeth, JD and Carey, CL (2004) Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug Alcohol Depend, 76, pp. 181-190.
76. Woods, SP, Rippeth, JD and Conover, E. (2005) Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence. Neuropsychology, 19, pp. 35-43.
77. Strickland, TL, Mena, I. and Villanueva-Meyer, J. (1993) Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci, 5, pp. 419-427.
78. Bolla, KI, Rothman, R. and Cadet, JL. (1999) Dose-related neurobehavioral effects of chronic cocaine use. J Neuropsychiatry Clin Neurosci, 11, pp. 361-369.
79. Rogers, RD and Robbins, TW. (2001) Investigating the neurocognitive deficits associated with chronic drug misuse. Curr Opin Neurobiol, 11, pp. 250-257.
80. Ardila, A., Rosselli, M. and Strumwasser, S. (1991) Neuropsychological deficits in chronic cocaine abusers. Int J Neurosci, 57, pp. 73-79.
81. Gouzoulis-Mayfrank, E., Schreckenberger, M. and Sabri, O. (1999) Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG. Neuropsychopharmacology, 20, pp. 565-581.
82. Iyo, M., Namba, H., Yanagisawa, M., Hirai, S., Yui, N. and Fukui, S. (1997) Abnormal cerebral perfusion in chronic methamphetamine abusers: A study using 99MTc-HMPAO and SPECT. Prog Neuropsychopharmacol Biol Psychiatry, 21, pp. 789-796.
83. Volkow, ND, Chang, L. and Wang, GJ (2001) Low level of brain dopamine D2 receptors in methamphetamine abusers: Association with metabolism in the orbitofrontal cortex. Am J Psychiatry, 158, pp. 2015-2021.
84. Volkow, ND, Chang, L. and Wang, GJ (2001) Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci, 21, pp. 9414-9418.
85. Volkow, ND, Chang, L. and Wang, GJ (2001) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry, 158, pp. 377-382.
86. Thompson, PM, Hayashi, KM and Simon, SL (2004) Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci, 24, pp. 6028-6036.
87. Ernst, T., Chang, L., Leonido-Yee, M. and Speck, O. (2000) Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology, 54, pp. 1344-1349.
88. Nordahl, TE, Salo, R. and Natsuaki, Y. (2005) Methamphetamine users in sustained abstinence: A proton magnetic resonance spectroscopy study. Arch Gen Psychiatry, 62, pp. 444-452.
89. Nordahl, TE, Salo, R. and Possin, K. (2002) Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: A preliminary proton MRS study. Magnetic resonance spectroscopy. Psychiatry Res, 116, pp. 43-52.
90. Bartzokis, G., Beckson, M. and Lu, PH (2000) Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research. Psychiatry Res, 98, pp. 93-102.
91. Sclafani, V Di, Tolou-Shams, M., Price, LJ and Fein, G. (2002) Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug Alcohol Depend, 66, pp. 161-171.
92. Fein, G., Sclafani, V Di and Meyerhoff, DJ. (2002) Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men. Drug Alcohol Depend, 68, pp. 87-93.
93. Gouzoulis-Mayfrank, E. and Daumann, J. (2006) Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: How strong is the evidence for persistent brain damage?. Addiction, 101, pp. 348-361.
94. McGuire, P. (2000) Long term psychiatric and cognitive effects of MDMA use. Toxicol Lett, 112, pp. 153-156.
95. Montoya, AG, Sorrentino, R., Lukas, SE and Price, BH. (2002) Long-term neuropsychiatric consequences of "ecstasy" (MDMA): A review. Harv Rev Psychiatry, 10, pp. 212-220.
96. Bolla, KI, McCann, UD and Ricaurte, GA. (1998) Memory impairment in abstinent MDMA ("Ecstasy") users. Neurology, 51, pp. 1532-1537.
97. McCardle, K., Luebbers, S., Carter, JD, Croft, RJ and Stough, C. (2004) Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology (Berl), 173, pp. 434-439.
98. Morgan, MJ, Impallomeni, LC, Pirona, A. and Rogers, RD. (2006) Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naive controls. Neuropsychopharmacology, 31, pp. 1562-1573.
99. Spatt, J., Glawar, B. and Mamoli, B. (1997) A pure amnestic syndrome after MDMA ("ecstasy") ingestion. J Neurol Neurosurg Psychiatry, 62, pp. 418-419.
100. Jacobsen, LK, Mencl, WE, Pugh, KR, Skudlarski, P. and Krystal, JH. (2004) Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: Possible relationship to neurotoxic effects. Psychopharmacology (Berl), 173, pp. 383-390.
101. Daumann, J., Fischermann, T., Heekeren, K., Henke, K., Thron, A. and Gouzoulis-Mayfrank, E. (2005) Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users. Psychopharmacology (Berl), 180, pp. 607-611.
102. Daumann Jr, J., Fischermann, T., Heekeren, K., Thron, A. and Gouzoulis-Mayfrank, E. (2004) Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: Evidence from an 18-month longitudinal functional magnetic resonance imaging study. Biol Psychiatry, 56, pp. 349-355.
103. Daumann, J., Pelz, S., Becker, S., Tuchtenhagen, F. and Gouzoulis-Mayfrank, E. (2001) Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use. Hum Psychopharmacol, 16, pp. 627-633.
104. Daumann, J., Schnitker, R., Weidemann, J., Schnell, K., Thron, A. and Gouzoulis-Mayfrank, E. (2003) Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users. Neuroreport, 14, pp. 1983-1987.
105. Cowan, RL, Lyoo, IK and Sung, SM (2003) Reduced cortical gray matter density in human MDMA (Ecstasy) users: A voxel-based morphometry study. Drug Alcohol Depend, 72, pp. 225-235.
106. Morgan, MJ, McFie, L., Fleetwood, H. and Robinson, JA. (2002) Ecstasy (MDMA): Are the psychological problems associated with its use reversed by prolonged abstinence?. Psychopharmacology (Berl), 159, pp. 294-303.
107. Jacobsen, LK, Pugh, KR, Constable, RT, Westerveld, M. and Mencl, WE. (2007) Functional correlates of verbal memory deficits emerging during nicotine withdrawal in abstinent adolescent cannabis users. Biol Psychiatry, 61, pp. 31-40.
108. Lewinsohn, PM, Hops, H., Roberts, RE, Seeley, JR and Andrews, JA. (1993) Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol, 102, pp. 133-144.
109. Hasin, DS, Goodwin, RD, Stinson, FS and Grant, BF. (2005) Epidemiology of major depressive disorder: Results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry, 62, pp. 1097-1106.
110. Button, TM, Hewitt, JK, Rhee, SH, Young, SE, Corley, RP and Stallings, MC. (2006) Examination of the causes of covariation between conduct disorder symptoms and vulnerability to drug dependence. Twin Res Hum Genet, 9, pp. 38-45.
111. Conway, KP, Compton, W., Stinson, FS and Grant, BF. (2006) Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry, 67, pp. 247-257.
112. Kantojarvi, L., Veijola, J. and Laksy, K. (2006) Co-occurrence of personality disorders with mood, anxiety, and substance use disorders in a young adult population. J Pers Disord, 20, pp. 102-112.
113. Hides, L., Lubman, DI and Dawe, S. (2004) Models of co-occurring substance misuse and psychosis: Are personality traits the missing link?. Drug Alcohol Rev, 23, pp. 425-432.
114. Swartz, MS, Wagner, HR and Swanson, JW (2006) Substance use in persons with schizophrenia: Baseline prevalence and correlates from the NIMH CATIE study. J Nerv Ment Dis, 194, pp. 164-172.
115. Bogenschutz, MP and Nurnberg, HG. (2000) Theoretical and methodological issues in psychiatric comorbidity. Harv Rev Psychiatry, 8, pp. 18-24.
116. Brady, KT and Sinha, R. (2005) Co-occurring mental and substance use disorders: The neurobiological effects of chronic stress. Am J Psychiatry, 162, pp. 1483-1493.
117. Tarter, RE, Kirisci, L. and Mezzich, A. (2003) Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder. Am J Psychiatry, 160, pp. 1078-1085.
118. Acton, GS. (2003) Measurement of impulsivity in a hierarchical model of personality traits: Implications for substance use. Subst Use Misuse, 38, pp. 67-83.
119. Stepp, SD, Trull, TJ and Sher, KJ. (2005) Borderline personality features predict alcohol use problems. J Pers Disord, 19, pp. 711-722.
120. Dawe, S., Gullo, MJ and Loxton, NJ. (2004) Reward drive and rash impulsiveness as dimensions of impulsivity: Implications for substance misuse. Addict Behav, 29, pp. 1389-1405.
121. Chassin, L., Fora, DB and King, KM. (2004) Trajectories of alcohol and drug use and dependence from adolescence to adulthood: The effects of familial alcoholism and personality. J Abnorm Psychol, 113, pp. 483-498.
122. Chassin, L., Pillow, DR, Curran, PJ, Molina, BS and Barrera, M Jr. (1993) Relation of parental alcoholism to early adolescent substance use: A test of three mediating mechanisms. J Abnorm Psychol, 102, pp. 3-19.
123. Whittle, S., Allen, NB, Lubman, DI and Yucel, M. (2006) The neurobiological basis of temperament: Towards a better understanding of psychopathology. Neurosci Biobehav Rev, 30, pp. 511-525.
124. Kirisci, L., Tarter, RE, Vanyukov, M., Reynolds, M. and Habeych, M. (2004) Relation between cognitive distortions and neurobehavior disinhibition on the development of substance use during adolescence and substance use disorder by young adulthood: A prospective study. Drug Alcohol Depend, 76, pp. 125-133.
125. Giedd, JN, Blumenthal, J. and Jeffries, NO (1999) Brain development during childhood and adolescence: A longitudinal MRI study. Nat Neurosci, 2, pp. 861-863.
126. Gogtay, N., Giedd, JN and Lusk, L. (2004) Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA, 101, pp. 8174-8179.
127. Paus, T., Zijdenbos, A. and Worsley, K. (1999) Structural maturation of neural pathways in children and adolescents: In vivo study. Science, 283, pp. 1908-1911.
128. Paus, T. (2005) Mapping brain maturation and cognitive development during adolescence. Trends Cogn Sci, 9, pp. 60-68.
129. Steinberg, L. (2005) Cognitive and affective development in adolescence. Trends Cogn Sci, 9, pp. 69-74.
130. Scheier, LM and Botvin, GJ. (1995) Effects of early adolescent drug use on cognitive efficacy in early-late adolescence: A developmental structural model. J Subst Abuse, 7, pp. 379-404.
131. Lubman, DI, Yücel, M. and Hall, WD Substances and the adolescent brain: A toxic combination?. J Psychopharmacol
132. De Bellis, MD, Clark, DB and Beers, SR (2000) Hippocampal volume in adolescent-onset alcohol use disorders. Am J Psychiatry, 157, pp. 737-744.
133. De Bellis, MD, Narasimhan, A., Thatcher, DL, Keshavan, MS, Soloff, P. and Clark, DB. (2005) Prefrontal cortex, thalamus, and cerebellar volumes in adolescents and young adults with adolescent-onset alcohol use disorders and comorbid mental disorders. Alcohol Clin Exp Res, 29, pp. 1590-1600.
134. Wilson, W., Mathew, R., Turkington, T., Hawk, T., Coleman, RE and Provenzale, J. (2000) Brain morphological changes and early marijuana use: A magnetic resonance and positron emission tomography study. J Addict Dis, 19, pp. 1-22.
135. Medina, KL, Schweinsburg, AD, Cohen-Zion, M., Nagel, BJ and Tapert, SF. (2007) Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry. Neurotoxicol Teratol, 29, pp. 141-152.
136. Tapert, SF, Cheung, EH and Brown, GG (2003) Neural response to alcohol stimuli in adolescents with alcohol use disorder. Arch Gen Psychiatry, 60, pp. 727-735.
137. Kreek, MJ, Nielsen, DA, Butelman, ER and LaForge, KS. (2005) Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci, 8, pp. 1450-1457.
138. Diamond, A., Briand, L., Fossella, J. and Gehlbach, L. (2004) Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am J Psychiatry, 161, pp. 125-132.
139. Egan, MF, Goldberg, TE and Kolachana, BS (2001) Effect of COMT Val108/ 158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA, 98, pp. 6917-6922.
140. Malhotra, AK, Kestler, LJ, Mazzanti, C., Bates, JA, Goldberg, T. and Goldman, D. (2002) A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry, 159, pp. 652-654.
141. Beuten, J., Payne, TJ, Ma, JZ and Li, MD. (2006) Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations. Neuropsychopharmacology, 31, pp. 675-684.
142. Chen, CK (2004) Association analysis of the DRD4 and COMT genes in methamphetamine abuse. Am J Med Genet B Neuropsychiatr Genet, 129, pp. 120-124.